Skip to content

INFIPHAR

Active
Private limited companyfounded 201313 yrs activeAvendorenstraat 18, 3300 Tienen, BelgiumKBO/BCE: BE 0537.443.148

INFIPHAR has been active since 2013 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €97k and a net result of €79k. Equity remains stable across the filed fiscal years (±0% per year). Its solvency ranks better than 27% of 10250 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.7% (low).

Checked score

Score 2025
60 / 100
Healthy▼ -38 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency23▼-75
Growth58▼-20
Stability100
Bankruptcy probability, 12 months
0.7% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €6k at 30 days acceptable
Liquidity tight (current ratio 1.01 against 3.12 in 2024), and 82.8% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
17.2%
Return on assets
13.9%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 13 years 0 20 y
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-07-2026, 7 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
7 d early
2024
38 d early
2023
19 d early
2022
19 d early
2021
23 d early
2020
44 d late
2019
101 d late
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
16-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, abbreviated schema

Equity
€97k▼ 74.2%
2024 · €377k
2018: €313k 2019: €377k 2020: €377k 2021: €377k 2022: €377k 2023: €377k 2024: €377k
2018 → 2025
Total assets
€565k▼ 13.6%
2024 · €654k
2018: €763k 2019: €698k 2020: €737k 2021: €714k 2022: €659k 2023: €647k 2024: €654k
2018 → 2025
Net result
€79k▼ 28.2%
2024 · €110k
2018: €62k 2019: €65k 2020: €67k 2021: €76k 2022: €64k 2023: €73k 2024: €110k
2018 → 2025
Working capital
€4k▼ 98.8%
2024 · €304k
2018: €182k 2019: €256k 2020: €271k 2021: €308k 2022: €307k 2023: €320k 2024: €304k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€377k-€377k=€377k=€377k=€97k▼ 74.2%
Operating result€100k-€87k▼ 12.7%€95k▲ 8.5%€147k▲ 55.0%€104k▼ 29.3%
Net result€76k-€64k▼ 15.7%€73k▲ 15.1%€110k▲ 49.3%€79k▼ 28.2%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50k€100k€150kOperating result 2021: €100k€100kNet result 2021: €76k€76kOperating result 2022: €87k€87kNet result 2022: €64k€64kOperating result 2023: €95k€95kNet result 2023: €73k€73kOperating result 2024: €147k€147kNet result 2024: €110k€110kOperating result 2025: €104k€104kNet result 2025: €79k€79k20212022202320242025
The operating result falls in 2025; 2025 is 29% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €565k
Fixed assets €211k▲ 2.1%
Current assets €354k▼ 20.8%
Equity and liabilities €565k
Equity €97k▼ 74.2%
Debt €468k▲ 69.0%
The debt ratio rises from 42.3% to 82.8%: debt grows while equity shrinks.
Key figures and ratios
2025 value · change against 2024
EBITDA
€113k
2024 · €155k
Cash flow
€88k
2024 · €118k
Solvency
17.2%
2024 · 57.7%
Current ratio
1.01
2024 · 3.12
Quick ratio
0.69
2024 · 2.32
Debt / equity
4.81
2024 · 0.73
ROE
80.9%
2024 · 29.1%
ROA
13.9%
2024 · 16.8%
Interest coverage
16.97
2024 · 14.54
Debt
€468k
2024 · €277k
Debt ≤ 1 year
€351k
2024 · €144k
Debt > 1 year
€112k
2024 · €126k
Income taxes
€20k
2024 · €30k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€654k€565k
Fixed assets21/28€207k€211k
Tangible fixed assets22/27€204k€204k
Land and buildings22€202k€194k
Plant, machinery and equipment23€2k€6k
Furniture and vehicles24-€4k
Financial fixed assets28€2k€7k
Current assets29/58€448k€354k
Stocks and contracts in progress3€115k€114k
Stocks30/36€115k€114k
Amounts receivable within one year40/41€76k€77k
Trade receivables40€57k€70k
Other amounts receivable41€18k€7k
Cash at bank and in hand54/58€246k€152k
Deferred charges and accrued income490/1€11k€12k
Equity and liabilities
Total equity and liabilities10/49€654k€565k
Equity10/15€377k€97k
Contributions10/11€19k€19k=
Reserves13€359k€79k
Distributable reserves133€359k€79k
Profit (loss) carried forward14€0€0=
Amounts payable17/49€277k€468k
Amounts payable after more than one year17€126k€112k
Financial debts170/4€126k€112k
Amounts payable within one year42/48€144k€351k
Current portion of amounts payable after more than one year42€14k€14k
Trade debts44€15k€29k
Suppliers440/4€15k€29k
Taxes, remuneration and social security45€21k€4k
Taxes450/3€21k€4k
Other amounts payable47/48€93k€304k
Accrued charges and deferred income492/3€7k€5k
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€9k€10k
Other operating charges640/8€3k€4k
Gross operating margin9900€158k€117k
Operating profit (loss)9901€147k€104k
Financial income75/76B€3k€2k
Recurring financial income75€3k€2k
Financial charges65/66B€11k€7k
Recurring financial charges65€11k€7k
Profit (loss) for the period before taxes9903€140k€99k
Income taxes67/77€30k€20k
Profit (loss) for the period9904€110k€79k
Profit (loss) for the period to be appropriated9905€110k€79k
Appropriation of the result
Profit (loss) to be appropriated9906€110k€79k
Transfer from equity791/2-€359k
Transfer to equity691/2-€79k
To other reserves6921-€79k
Profit to be distributed694/7€110k€359k
Return on contributions (dividend)694€110k€359k
Social balance
Average headcount (FTE)90870.00.0=

The notes to these accounts (20 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
24-07
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
23-06
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial Highest result since 2018net €110k ▲49.3%
Operating result €147k, net result €110k, both a record.
12-07
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
12-07
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
08-07
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
13-09
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema · 44 days late
2020
09-11
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema · 101 days late
2019
31-12
Financial Liquidity doublescurrent ratio 5.22
Current ratio from 2.15 to 5.22; short-term debt falls from €158k to €61k.
19-08
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema · 19 days late
2018
24-07
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
20-07
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Tienen · 1 establishment unit since 2013
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Avendorenstraat 183300 Tienen
Ground area
1,553 m²
Building footprint
356 m²
Volume, LiDAR
3,555 m³
2 parcels, Flanders · tallest building 14.4 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
INFIPHAR
Vierde Lansierslaan 76, 3300 TienenRetail sale of pharmaceutical products
since 20132.221.120.747
2 parcels
Flanders 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
24592F0196/00B002 Flanders 1,345 m² 1 · 180 m² 13.7 m · 4 fl.
24592F0171/00B005
ProtectedTownscape or village viewStation Tienen met omgevingSource ↗
Flanders 207 m² 1 · 176 m² 14.4 m · 4 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
1 of these parcels carry protected heritage (source: regional heritage registers, Onroerend Erfgoed / patrimoine.brussels).

Similar companies · same sector, comparable size

Of 5,224 companies in sector 47730 we hold annual accounts for 3,864. 3,412 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded12-08-2013
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 12 filingsAddress and cadastre registers

Data from official sources, last processed on 16-09-2026. Scores and ratios are computed by Checked and are not a credit decision.